Japan Embarks On Rx-To-OTC Switch Revolution
The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches.
You may also be interested in...
Takeda is to offload its sizable Japanese OTC operation to private-equity firm Blackstone, which has committed to making the business the country's leading consumer health player.
HBW Insight Exclusive: A lack of regulatory harmonization, especially with regards to Rx-to-OTC switch, is holding the Asia-Pacific OTC market back, according to APSMI secretary general, Toshi Tominaga.
Takeda will divest a portfolio containing OTC drugs and dietary supplements to Denmark's Orifarm, while rumors suggest the company is poised to offload its substantial Japanese consumer healthcare business.